iCAD (ICAD) - Utang jangka dawa marang modal

Tandha merek iCAD Inc. (ICAD)

The historical price action of iCAD, Inc. (ICAD) demonstrates the impact of the transition to cloud subscriptions, which increases ARR and constitutes 0.00. The business relies on high-margin licensing of AI algorithms for mammogram analysis without production costs. Furthermore, the implementation of software in MRI centers creates long-term technical customer lock-in, ensuring regular payments for system updates for the developer.

icadmed.com (ICAD): Utang jangka dawa marang modal saka 04.07.2022 nganti 02.08.2025
Produk merek iCAD, Inc.

Assessing the debt load is critical for understanding the issuer's financial stability. This indicator measures the proportion of long-term borrowings relative to equity, determining the business's degree of dependence on external financing. By analyzing the ratio of liabilities exceeding one year to equity, an investor can track leverage dynamics. For iCAD, Inc. (ICAD), its high-margin SaaS model means a low debt level confirms the efficiency of free cash flow generation, which minimizes default risks while scaling AI solutions.

Perusahaan pesaing

Rasio utang jangka dawa marang ekuitas BeiGene Ltd.|Utang jangka dawa marang modal HALO|Utang jangka dawa marang modal RVMD (Revolution Medicines Corp)|AAPG - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal cgoncology.com CGON|URGN: Utang jangka dawa marang modal|BCAX - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal PSNL|ERAS (Erasca Oncology) - Kewajiban jangka dawa marang modal|DCTH - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal ymabs.com (YMAB)|Aura Biosciences (AURA) - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal candeltx.com (CADL)|Accuray Inc. - Utang jangka dawa marang modal|SLS - Rasio utang jangka dawa marang ekuitas|Actuate Therapeutics, Inc. - Rasio utang jangka dawa marang ekuitas|CTOR: Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas tuhurabio.com HURA|Protara Therapeutics Inc (TARA) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal FATE (Fate Therapeutics Corp)|Kewajiban jangka dawa marang modal Aadi Bio|TCRX (TScan Therapeutics) - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal championsoncology.com (CSBR)|XBiotech - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas CEL-SCI Corp. CVM|OS Therapies Inc - Utang jangka dawa marang modal|RADX - Utang jangka dawa marang modal|Utang jangka dawa marang modal artivabio.com|Rasio utang jangka dawa marang modal Adlai Nortye|VERU - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal Tempest Therapeutics Inc|XLO (Xilio Therapeutics, Inc.) - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal RENB (renovarobio.com)|MURA - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang modal Kairos Pharma Limited KAPA|OKUR: Utang jangka dawa marang modal|CytoMed Therapeutics (GDTC) - Rasio utang jangka dawa marang ekuitas|curis.com - Rasio utang jangka dawa marang ekuitas|Apollomics (APLM) - Rasio tanggungan utang jangka dawa marang modal|THAR: Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal Advanced Biomed Corp|Utang jangka dawa marang modal GNPX (Genprex)|Rasio utang jangka dawa marang ekuitas calidibio.com (CLDI)|Utang jangka dawa marang modal SBFM (Sunshine Biopharma)|Utang jangka dawa marang modal Xenetic Biosciences Inc. XBIO|Salarius Pharmaceuticals (SLRX) - Utang jangka dawa marang modal|PPBT - Rasio utang jangka dawa marang modal|AONC (aoncology.com) - Utang jangka dawa marang modal|BeiGene Ltd. (BGNE) - Rasio utang jangka dawa marang ekuitas|CKPT (Checkpoint Therapeutics, Inc) - Utang jangka dawa marang modal|Utang jangka dawa marang modal ELEV|Utang jangka dawa marang ekuitas Ikena Oncology, Inc. IKNA|Rasio utang jangka dawa marang modal notablelabs.com (NTBL)|Viracta Therapeutics, Inc. - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas MorphoSys Inc MOR|NAYA (NAYA Bio) - Utang jangka dawa marang modal|AAPGV: Kewajiban jangka dawa marang modal